Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5 homo- and hetero-dimer formation. | Front Endocrinol (Lausanne) | 2022 | 35992099 | PubTator, text mining | PubMed |
| Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly. | Endocrine | 2022 | 35986839 | PubTator, text mining | PubMed |
| WITHDRAWN: Identification of Key Biomarkers for the Future Applications in Diagnostics and Targeted Therapy of Colorectal Cancer | Curr Mol Med | 2022 | 35986538 | PubTator, text mining | PubMed |
| Multimodal imaging of capsid and cargo reveals differential brain targeting and liver detargeting of systemically-administered AAVs. | Biomaterials | 2022 | 35985893 | PubTator, text mining | PubMed |
| Construction and validation of a glioblastoma prognostic model based on immune-related genes. | Front Neurol | 2022 | 35968275 | PubTator, text mining | PubMed |
| 3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals. | Theranostics | 2022 | 35966589 | PubTator, text mining | PubMed |
| Lymphoepithelial carcinoma of the salivary gland-A great cytologic mimicker in the head and neck region, and the first report of SSTR2 expression on cytologic material. | Diagn Cytopathol | 2022 | 35962726 | PubTator, text mining | PubMed |
| Advances in nuclear medicine-based molecular imaging in head and neck squamous cell carcinoma. | J Transl Med | 2022 | 35962347 | PubTator, text mining | PubMed |
| MicroRNA in Acromegaly: Involvement in the Pathogenesis and in the Response to First-Generation Somatostatin Receptor Ligands. | Int J Mol Sci | 2022 | 35955787 | PubTator, text mining | PubMed |
| Reporter Genes for Brain Imaging Using MRI, SPECT and PET. | Int J Mol Sci | 2022 | 35955578 | PubTator, text mining | PubMed |
| Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 35954436 | PubTator, text mining | PubMed |
| CHST7 Methylation Status Related to the Proliferation and Differentiation of Pituitary Adenomas. | Cells | 2022 | 35954244 | PubTator, text mining | PubMed |
| The neuropeptide landscape of human prefrontal cortex. | Proc Natl Acad Sci U S A | 2022 | 35947618 | PubTator, text mining | PubMed |
| Hormone supply to the pituitary gland: A comprehensive investigation of female‑related tumors (Review). | Int J Mol Med | 2022 | 35946461 | PubTator, text mining | PubMed |
| A case of Lymphoplasmacyte-rich meningioma mimicking pachymeningitis. | BMC Neurol | 2022 | 35906535 | PubTator, text mining | PubMed |
| Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches. | Front Endocrinol (Lausanne) | 2022 | 35903274 | PubTator, text mining | PubMed |
| Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. | J Immunother Cancer | 2022 | 35902131 | PubTator, text mining | PubMed |
| Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques. | Tomography | 2022 | 35894012 | PubTator, text mining | PubMed |
| Radionuclide Delivery Strategies in Tumor Treatment: A Systematic Review. | Curr Issues Mol Biol | 2022 | 35892711 | PubTator, text mining | PubMed |
| Short-Interval, Low-Dose Peptide Receptor Radionuclide Therapy in Combination with PD-1 Checkpoint Immunotherapy Induces Remission in Immunocompromised Patients with Metastatic Merkel Cell Carcinoma. | Pharmaceutics | 2022 | 35890361 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=47